ReviewMolecular medicine reports2026
Advances in the mechanisms of extracellular vesicles and circulating tumor cells in hepatocellular carcinoma metastasis (Review).
Review in Molecular medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metastasis of hepatocellular carcinoma (HCC) is a key factor contributing to poor patient prognosis, with extracellular vesicles (EVs) and circulating tumor cells (CTCs) playing a marked synergistic role in this process. Current research suggests that EVs, acting as essential mediators of intercellular communication, facilitate CTC‑driven HCC recurrence and metastasis by transporting bioactive molecules, including nucleic acids, proteins and lipids. CTCs are regarded as the initiators of tumor metastasis, while the bioactive cargo carried by EVs functions as critical factors that promote their outgrowth. EVs not only remodel the microenvironment of target organs by forming a 'pre‑metastatic niche', but also establish a permissive microenvironment for CTC colonization. This tripartite interplay establishes a cascade model that enhances metastatic dissemination. The present manuscript reviewed the recent advancements and clinical value in understanding the roles of EVs and CTCs in HCC metastasis and recurrence, as well as the mechanisms by which EVs mediate CTC‑driven liver cancer spread, aiming to promote further in‑depth research into HCC metastasis mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.